A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

A. M. Wilson, L. C. Orr, W. J. R. Coutie, E. J. Sims, B. J. Lipworth

    Research output: Contribution to journalArticle

    53 Citations (Scopus)

    Abstract

    The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.
    Original languageEnglish
    Pages (from-to)126-32
    Number of pages7
    JournalClinical and Experimental Allergy
    Volume32
    Issue number1
    DOIs
    Publication statusPublished - Jan 2002

    Fingerprint Dive into the research topics of 'A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis'. Together they form a unique fingerprint.

  • Cite this